India’s real cancer incidence for women is estimated at 1 to 1.4 million per year. In 2015 reported incidence was 0.7 million (third highest after China and the USA) growing at a CAGR of 4.5-5%.
Expanding cancer care for women in India
Japan: leading the way in regenerative medicine
Putting China's capital to work in the West
Streamlining drug development — at scale
Embedding digital into pharma's DNA
Augmenting R&D with artificial intelligence
Value-based healthcare and Value Labs
Cost of Capital- India Survey for the Lifesciences sector
Life sciences dealmaking expected to continue
Life Sciences Industry
Life Sciences Consulting Services
Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.
Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in Advisory, Assurance, Tax and Transactions.